Literature DB >> 27609838

Emerging roles of the single EF-hand Ca2+ sensor tescalcin in the regulation of gene expression, cell growth and differentiation.

Ksenia G Kolobynina1, Valeria V Solovyova1, Konstantin Levay2, Albert A Rizvanov1, Vladlen Z Slepak3.   

Abstract

Tescalcin (TESC, also known as calcineurin-homologous protein 3, CHP3) is a 24-kDa EF-hand Ca2+-binding protein that has recently emerged as a regulator of cell differentiation and growth. The TESC gene has also been linked to human brain abnormalities, and high expression of tescalcin has been found in several cancers. The expression level of tescalcin changes dramatically during development and upon signal-induced cell differentiation. Recent studies have shown that tescalcin is not only subjected to up- or down-regulation, but also has an active role in pathways that drive cell growth and differentiation programs. At the molecular level, there is compelling experimental evidence showing that tescalcin can directly interact with and regulate the activities of the Na+/H+ exchanger NHE1, subunit 4 of the COP9 signalosome (CSN4) and protein kinase glycogen-synthase kinase 3 (GSK3). In hematopoetic precursor cells, tescalcin has been shown to couple activation of the extracellular signal-regulated kinase (ERK) cascade to the expression of transcription factors that control cell differentiation. The purpose of this Commentary is to summarize recent efforts that have served to characterize the biochemical, genetic and physiological attributes of tescalcin, and its unique role in the regulation of various cellular functions.
© 2016. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  CHP3; COP9; Differentiation; GSK3; NHE1; Tescalcin

Mesh:

Substances:

Year:  2016        PMID: 27609838      PMCID: PMC5087652          DOI: 10.1242/jcs.191486

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  64 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  Nuclear-localized calcineurin homologous protein CHP1 interacts with upstream binding factor and inhibits ribosomal RNA synthesis.

Authors:  Maite Jiménez-Vidal; Jyoti Srivastava; Luanna K Putney; Diane L Barber
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

3.  Crystal structure of CHP2 complexed with NHE1-cytosolic region and an implication for pH regulation.

Authors:  Youssef Ben Ammar; Soichi Takeda; Takashi Hisamitsu; Hidezo Mori; Shigeo Wakabayashi
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

Review 4.  ETS transcription factors in endocrine systems.

Authors:  Arthur Gutierrez-Hartmann; Dawn L Duval; Andrew P Bradford
Journal:  Trends Endocrinol Metab       Date:  2007-03-26       Impact factor: 12.015

5.  A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML.

Authors:  Cheuk Him Man; Stephen S Y Lam; Murphy K H Sun; Howard C H Chow; Harinder Gill; Yok Lam Kwong; Anskar Y H Leung
Journal:  Blood       Date:  2014-03-07       Impact factor: 22.113

6.  Carp muscle calcium-binding protein. II. Structure determination and general description.

Authors:  R H Kretsinger; C E Nockolds
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

Review 7.  Mg2+/Ca2+ cation binding cycle of guanylyl cyclase activating proteins (GCAPs): role in regulation of photoreceptor guanylyl cyclase.

Authors:  Alexander M Dizhoor; Elena V Olshevskaya; Igor V Peshenko
Journal:  Mol Cell Biochem       Date:  2009-12-02       Impact factor: 3.396

8.  Dissection of calbindin D9k into two Ca(2+)-binding subdomains by a combination of mutagenesis and chemical cleavage.

Authors:  B E Finn; J Kördel; E Thulin; P Sellers; S Forsén
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

9.  Biological actions and mechanism of action of calbindin in the process of apoptosis.

Authors:  Sylvia Christakos; Yan Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

10.  The Na+/H+ exchanger cytoplasmic tail: structure, function, and interactions with tescalcin.

Authors:  Xiuju Li; Yongsheng Liu; Cyril M Kay; Werner Müller-Esterl; Larry Fliegel
Journal:  Biochemistry       Date:  2003-06-24       Impact factor: 3.162

View more
  7 in total

Review 1.  Structural and functional diversity of EF-hand proteins: Evolutionary perspectives.

Authors:  Hiroshi Kawasaki; Robert H Kretsinger
Journal:  Protein Sci       Date:  2017-07-27       Impact factor: 6.725

2.  The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Massimo Libra
Journal:  Immunogenetics       Date:  2022-02-16       Impact factor: 2.846

3.  Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.

Authors:  Xiuhe Zou; Qian Zhou; Yan Nie; Junhe Gou; Jing Yang; Jingqiang Zhu; Zhihui Li; Yanping Gong
Journal:  BMC Cancer       Date:  2022-05-31       Impact factor: 4.638

4.  Calcineurin B homologous protein 3 binds with high affinity to the CHP binding domain of the human sodium/proton exchanger NHE1.

Authors:  Simon Fuchs; Sierra C Hansen; Marie Markones; Evgeny V Mymrikov; Heiko Heerklotz; Carola Hunte
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379

5.  TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma.

Authors:  Cheng-Han Hsieh; Cheng-Ying Chu; Sey-En Lin; Yu-Chen S H Yang; Hung-Shu Chang; Yun Yen
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

6.  Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.

Authors:  Zhong-Guo Zhou; Jin-Bin Chen; Rong-Xin Zhang; Ling Ye; Jun-Cheng Wang; Yang-Xun Pan; Xiao-Hui Wang; Wen-Xuan Li; Yao-Jun Zhang; Li Xu; Min-Shan Chen
Journal:  Cancer Commun (Lond)       Date:  2020-07-01

7.  Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis.

Authors:  Yuxia Fan; Xin Fan; Hao Yan; Zheng Liu; Xiaoming Wang; Qingling Yuan; Jie Xie; Xiubo Lu; Yang Yang
Journal:  Cell Death Dis       Date:  2022-02-16       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.